Citi Downgrades Ultragenyx Pharma (RARE) to Sell
Tweet
Share
E-mailGet Alerts RARE Hot Sheet
Price: $25.83 +2.01%
Rating Summary:
21 Buy, 4 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
21 Buy, 4 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Citi downgraded Ultragenyx Pharma (NASDAQ: RARE) from Neutral to Sell.
For an analyst ratings summary and ratings history on Ultragenyx Pharma click here. For more ratings news on Ultragenyx Pharma click here.
Shares of Ultragenyx Pharma closed at $82.06 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ultragenyx Pharma (RARE) PT Raised to $83 at Canaccord
- DZ Bank Downgrades Frontline Ltd. (FRO) to Sell
- Goldman Sachs Downgrades Kuaishou Technology (1024:HK) to Neutral
Create E-mail Alert Related Categories
Downgrades, Hot DowngradesRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
